Anonymous User
Login / Registration

Gastroenterologie
a hepatologie

Gastroenterology and Hepatology

Gastroent Hepatol 2017; 71(2): 101–104. doi:10.14735/amgh2017101.

Czech Society of Hepatology guidelines for diagnosis and treatment of acute porphyrias

Radan Brůha Orcid.org  1, Libor Vítek Orcid.org  , Jan Šperl Orcid.org  2, Petr Urbánek Orcid.org  3

+ Affiliation

To read this article in full, please register for free on this website.

Benefits for subscribers

Benefits for logged users

Literature

1. Meyer UA, Strand LJ, Doss M et al.  Intermittent acute porphyria – demonstration of a genetic defect in porphobilinogen metabolism. N Engl J Med 1972; 286 (24): 1277–1282.
2. Elder G, Harper P, Badminton M et al. The incidence of inherited porphyrias in Europe. J Inherit Metab Dis 2013; 36 (5): 849–857. doi: 10.1007/s10545-012-9544-4.
3. Ehrmann J, Hůlek P (eds). Hepatologie. Praha: Grada Publishing 2010: 616.
4. Welsh Medicines Information Centre. Drugs that are considered to be SAFE for use in the acute porphyrias. [online]. Available from: www.wmic.wales.nhs.uk/wp-content/uploads/2016/07/2016-porphyria-safe-list-FINAL.pdf.
5. European Porphyria Network. Available from: http: //porphyria.eu/en/content/ home.
6. Warren MJ, Cooper JB, Wood SP et al. Lead poisoning, haem synthesis and 5-aminolaevulinic acid dehydratase. Trends Biochem Sci 1998; 23 (6): 217–221.
7. Pischik E, Kauppinen R. An update of clinical management of acute intermittent porphyria. Appl Clin Genet 2015; 8: 201–214. doi: 10.2147/TACG.S48605.
8. Kauppinen R. Porphyrias. Lancet 2005; 365 (9455): 241–252.
9. Herrick AL, McColl KE, Moore MR et al. Controlled trial of haem arginate in acute hepatic porphyria. Lancet 1989; 1 (8650): 1295–1297.
10. Stein P, Badminton M, Barth J et al. Best practice guidelines on clinical management of acute attacks of porphyria and their complications. Ann Clin Biochem 2013; 50 (Pt 3): 217–223. doi: 10.1177/ 0004563212474555.

 

Credited self-teaching test